Featured Research

from universities, journals, and other organizations

Older Donor Hearts Just As Good, Study Shows

Date:
April 14, 2006
Source:
University of Alberta
Summary:
Patients who receive healthy hearts from donors 50 years of age and older appear to fare just as well as patients who receive younger hearts, and that may be good news for potentially expanding a small donor pool, a University of Alberta study has found.

Patients who receive healthy hearts from donors 50 years of age and older appear to fare just as well as patients who receive younger hearts, and that may be good news for potentially expanding a small donor pool, a University of Alberta study has found.

A study published in the March/April 2006 issue Journal of Cardiac Surgery reviewed the outcomes of using heart donors 50 years of age and older and discovered that there were no differences in ICU or post-operative length of hospital stay, days ventilated, or early rejection episodes.

The researchers analyzed 338 cardiac adult transplants performed at the University of Alberta Hospital between 1988 and 2002. Of those, 284 patients received hearts from donors under 50 and 54 received hearts aged 50 and older.

Recipients of the older hearts had a greater risk of death within 30 days of surgery, and pretransplant diabetes also played a significant role in survival, but despite that, long-term outcomes were similar to those of younger donor hearts. Both sets of patients had similar survival rates--at the end of 10 years, the survival rate for older hearts was 58 per cent versus 59 per cent for patients with younger donor hearts.

The research is good news for patients who will need heart transplants, said one of the study's co-authors, Dr. Shaohua Wang of the University of Alberta's Division of Cardiac Surgery. "As the population ages, it can be expected that the number of patients requiring transplantations will also increase."

Currently in North America, about 25 per cent of patients waiting for hearts will die each year due to lack of organs. Criteria for organ donations have traditionally been strict and older age has often been used to exclude potential donors, the study noted.

"If we can expand the donor pool by using older donors, we will be able to save more lives," Dr. Wang said.


Story Source:

The above story is based on materials provided by University of Alberta. Note: Materials may be edited for content and length.


Cite This Page:

University of Alberta. "Older Donor Hearts Just As Good, Study Shows." ScienceDaily. ScienceDaily, 14 April 2006. <www.sciencedaily.com/releases/2006/04/060414005411.htm>.
University of Alberta. (2006, April 14). Older Donor Hearts Just As Good, Study Shows. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2006/04/060414005411.htm
University of Alberta. "Older Donor Hearts Just As Good, Study Shows." ScienceDaily. www.sciencedaily.com/releases/2006/04/060414005411.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins